FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4784011000036104: Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, actuation (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2690831000168118 Seretide MDI 50/25 inhalation, actuation en Synonym Active Case sensitive Australian Medicines Terminology module
2690841000168110 Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, actuation (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide MDI 50/25 inhalation, actuation has manufactured dose form inhalation true Inferred relationship Some
Seretide MDI 50/25 inhalation, actuation has unit of use actuation true Inferred relationship Some 2043069133
Seretide MDI 50/25 inhalation, actuation has intended active ingredient fluticasone false Inferred relationship Some 1123078394
Seretide MDI 50/25 inhalation, actuation has intended active ingredient salmeterol true Inferred relationship Some 2043069132
Seretide MDI 50/25 inhalation, actuation has Australian BoSS salmeterol true Inferred relationship Some 2043069132
Seretide MDI 50/25 inhalation, actuation Is a trade product unit of use true Inferred relationship Some
Seretide MDI 50/25 inhalation, actuation Is a Seretide MDI 50/25 true Inferred relationship Some
Seretide MDI 50/25 inhalation, actuation Is a fluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation, actuation true Inferred relationship Some
Seretide MDI 50/25 inhalation, actuation has Australian BoSS fluticasone propionate false Inferred relationship Some 1123078394
Seretide MDI 50/25 inhalation, actuation has manufactured dose form pressurised inhalation false Inferred relationship Some
Seretide MDI 50/25 inhalation, actuation has Australian BoSS fluticasone propionate true Inferred relationship Some 829675386
Seretide MDI 50/25 inhalation, actuation has intended active ingredient fluticasone propionate true Inferred relationship Some 829675386
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide MDI 50/25 inhalation, 120 actuations has TPUU True Seretide MDI 50/25 inhalation, actuation Inferred relationship Some 1
Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, 120 actuations, aerosol can (containered trade product pack) has TPUU True Seretide MDI 50/25 inhalation, actuation Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start